CTOs on the Move

Thrasos Therapeutics

www.thrasos.com

 
Thrasos is a private, clinical-stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. The company's lead compound, THR-184 is currently being evaluated in a Phase 2 clinical study for the prevention of AKI in patients undergoing cardiac surgery. Thrasos is also developing compounds for diabetic nephropathy, a major cause of chronic kidney disease
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.thrasos.com
  • 2000 Rue Peel
    Montreal, AB CAN H3A 2W5
  • Phone: 514.940.2714

Executives

Name Title Contact Details

Similar Companies

BMG Labtech

BMG Labtech is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

British Columbia Cancer Agcy

British Columbia Cancer Agcy is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CERN Foundation

CERN Foundation is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SeLux Diagnostics

SeLux Diagnostics is developing a Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital acquired infections, and help combat the global antibiotic resistance epidemic.

Apic Bio

Apic Bio is committed to finding cures for patients with genetic diseases.